Skip to main content

Research Repository

Advanced Search

All Outputs (154)

E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study (2024)
Presentation / Conference
Cox, N., Kettle, C., Wang, H., Dutta, S., Packham, J., Galloway, J., …Scott, I. C. (2024, April). E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Electronic patient-reported outcome measures (ePROMs) assessing disease activity, function, pain, and quality of life can facilitate innovative inflammatory arthritis (IA) care, such as automating patient-initiated follow-up. This mix... Read More about E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study.

E006 Providing information on arthritis medication: a service evaluation (2024)
Presentation / Conference
Ryan, S., Hider, S., & Paskins, Z. (2024, April). E006 Providing information on arthritis medication: a service evaluation. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Traditionally patients commencing disease modifying anti-rheumatic medications (DMARDs) attended a face to face consultation with a rheumatology nurse or pharmacist, to discuss benefits, concerns and safety monitoring. The pandemic ha... Read More about E006 Providing information on arthritis medication: a service evaluation.

P187 Fatigue in people with polymyalgia rheumatica: a key unmet need? (2024)
Presentation / Conference
Muller, S., Belcher, J., Hider, S., Helliwell, T., & Mallen, C. D. (2024, April). P187 Fatigue in people with polymyalgia rheumatica: a key unmet need?. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Polymyalgia rheumatica (PMR) is common in older adults, causing severe pain and stiffness, particularly in the shoulder and hip girdles. Glucocorticoids treatment generally focusses on reducing pain and stiffness, but there are other... Read More about P187 Fatigue in people with polymyalgia rheumatica: a key unmet need?.

P185 Anatomical patterns of pain in primary care patients with polymyalgia rheumatica compared to the general population (2024)
Presentation / Conference
Hammad, N., Partington, R., Hider, S., Butt, H., Helliwell, T., Mallen, C., & Muller, S. (2024, April). P185 Anatomical patterns of pain in primary care patients with polymyalgia rheumatica compared to the general population. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Polymyalgia rheumatica (PMR) is common in older adults, causing severe pain and stiffness, particularly in the shoulder and hip girdles. A tapered course of glucocorticoids is recommended, but not always straightforward, with frequent... Read More about P185 Anatomical patterns of pain in primary care patients with polymyalgia rheumatica compared to the general population.

P182 Exercise and activity in polymyalgia rheumatica: co-creating an education resource acceptable to patients and health professionals (2024)
Presentation / Conference
O’Brien, A. V., Eng, S., Mackie, S. L., Scrafton, N., Hider, S., Tan, A. L., …Baxter, M. (2024, April). P182 Exercise and activity in polymyalgia rheumatica: co-creating an education resource acceptable to patients and health professionals. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims People with PMR report experiencing pain, stiffness and weakness, often impacting everyday tasks. Many fear exercise will exacerbate symptoms and need reassurance that exercise is helpful and not harmful. However, no PMR-specific, exe... Read More about P182 Exercise and activity in polymyalgia rheumatica: co-creating an education resource acceptable to patients and health professionals.

P064 It’s a long time to wait: exploring the support needs of people with rheumatoid arthritis starting methotrexate (2024)
Presentation / Conference
Logan, S. J., Hider, S., Green, J., & Ryan, S. (2024, April). P064 It’s a long time to wait: exploring the support needs of people with rheumatoid arthritis starting methotrexate. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Methotrexate (MTX) is recommended as initial Disease Modifying Anti-Rheumatic Drug (DMARD) therapy for people with Rheumatoid Arthritis (RA) but often takes several months to become effective. Little is known about the support needs o... Read More about P064 It’s a long time to wait: exploring the support needs of people with rheumatoid arthritis starting methotrexate.

OA32 A national survey of rheumatology telephone adviceline support in the United Kingdom: frontline perspectives (2024)
Presentation / Conference
Ryan, S., Hider, S., & Hassell, A. (2024, April). OA32 A national survey of rheumatology telephone adviceline support in the United Kingdom: frontline perspectives. Presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Telephone advicelines (TALs) are a core feature of rheumatology services and highly valued by patients for providing clinical advice and support. The demand for TALs has increased since the pandemic, placing pressure on current capaci... Read More about OA32 A national survey of rheumatology telephone adviceline support in the United Kingdom: frontline perspectives.

Reviews for multimorbidity risk in people with inflammatory conditions: a qualitative study. (2024)
Journal Article
Gray, L., Bullock, L., Chew-Graham, C. A., Jinks, C., Paskins, Z., & Hider, S. (in press). Reviews for multimorbidity risk in people with inflammatory conditions: a qualitative study. British Journal of General Practice Open (BJGP Open), BJGPO.2024.0011. https://doi.org/10.3399/BJGPO.2024.0011

People with inflammatory rheumatological conditions (IRCs) are at high risk of developing other conditions including cardiovascular disease and mood disorders. To explore perspectives of people with IRCs and healthcare practitioners (HCPs) on the con... Read More about Reviews for multimorbidity risk in people with inflammatory conditions: a qualitative study..

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial (2024)
Journal Article
Cope, A. P., Jasenecova, M., Vasconcelos, J. C., Filer, A., Raza, K., Qureshi, S., …Quick, V. (2024). Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial. The Lancet, 403(10429), 838-849. https://doi.org/10.1016/s0140-6736%2823%2902649-1

The information required by people with inflammatory arthritis to take methotrexate: a mixed-methods systematic review (2024)
Journal Article
Logan, S. J., Hider, S., Green, J., & Ryan, S. J. (in press). The information required by people with inflammatory arthritis to take methotrexate: a mixed-methods systematic review. Rheumatology, https://doi.org/10.1093/rheumatology/keae055

Objectives This mixed-methods systematic review aimed to identify and synthesize knowledge of the characteristics, content, and preferred format of information to support people with inflammatory arthritis (IA) to take methotrexate. Methods A literat... Read More about The information required by people with inflammatory arthritis to take methotrexate: a mixed-methods systematic review.

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial (2023)
Journal Article
Abhishek, A., Peckham, N., Pade, C., Gibbons, J. M., Cureton, L., Francis, A., …Jones, C. (2024). Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology, 6(2), e92-e104. https://doi.org/10.1016/s2665-9913%2823%2900298-9

How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation survey (2023)
Journal Article
Prior, J. A., Roddy, E., Solis-Trapala, I., Cornwall, N., Jinks, C., Abhishek, A., …Hider, S. (in press). How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation survey. Rheumatology Advances in Practice, 7(3), Article rkad102. https://doi.org/10.1093/rap/rkad102

Analgesic Prescribing in Patients with Inflammatory Arthritis in England: Observational Studies in the Clinical Practice Research Datalink (2023)
Journal Article
Scott, I. C., Jordan, K. P., Twohig, H., Whittle, R., Muller, S., Hider, S. L., …Bailey, J. (2023). Analgesic Prescribing in Patients with Inflammatory Arthritis in England: Observational Studies in the Clinical Practice Research Datalink. Rheumatology, Article kead463. https://doi.org/10.1093/rheumatology/kead463

Despite little evidence that analgesics are effective in inflammatory arthritis (IA), studies report substantial opioid prescribing. The extent this applies to other analgesics is uncertain. We undertook a comprehensive evaluation of analgesic prescr... Read More about Analgesic Prescribing in Patients with Inflammatory Arthritis in England: Observational Studies in the Clinical Practice Research Datalink.

Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review (2023)
Journal Article
Mudge, H. R., Honey, J. R., Tachoukaft, S., Hider, S. L., Mason, K. J., Welsh, V. K., & Burton, C. (in press). Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review. Arthritis Care & Research, 76(1), 40-48. https://doi.org/10.1002/acr.25227

Musculoskeletal symptoms are commonly reported following acute coronavirus disease 2019 (COVID‐19). It is unclear whether those with musculoskeletal symptoms subsequently develop inflammatory rheumatic musculoskeletal disease (iRMD). This review seek... Read More about Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review.

Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study. (2023)
Journal Article
Hawarden, A., Bullock, L., Chew-Graham, C., Herron, D., Hider, S., Jinks, C., …Paskins, Z. (2023). Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study. British Journal of General Practice Open (BJGP Open), 7(2), https://doi.org/10.3399/BJGPO.2022.0146

Background: People with inflammatory rheumatological conditions (IRCs) are at increased risk of common comorbidities including osteoporosis. Aim: To explore the barriers to and facilitators of implementing nurse-delivered fracture risk assessments... Read More about Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study..

OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE (2023)
Presentation / Conference
Logan, S., Hider, S., Green, J., & Ryan, S. (2023, May). OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE. Presented at EULAR 2023 European Congress of Rheumatology, Milan, Italy

Background Guidelines recommend that people with Inflammatory Arthritis have access to tailored information when starting treatment with Methotrexate (MTX) [1]. It is not known what information people with Inflammatory Arthritis (IA) need to take MTX... Read More about OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE.

AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION (2023)
Journal Article
Grey, L., Bullock, L., Chew-Graham, C. A., Jinks, C., Paskins, Z., Rule, T., & Hider, S. (2023). AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION. Annals of the Rheumatic Diseases, 82(Suppl 1), 2031 - 2031. https://doi.org/10.1136/annrheumdis-2023-eular.5564

Background: People with inflammatory rheumatological disorders (IRDs) are at high risk of developing multimorbidity, specifically cardiovascular disease (CVD) and mood problems. UK guidelines advocate annual reviews for people with Rheumatoid Arthrit... Read More about AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION.